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A significant proportion of previously activated human T cells undergo apoptosis when triggered 
through the CD3/T cell receptor complex, a process termed activation-induced cell death (AICD). 
Ligation of Fas on activated T  cells by either Fas antibodies or recombinant  human Fas-ligand 
(Fas-L) also results in cytolysis. We demonstrate that these two pathways of apoptosis are causally 
related.  Stimulation of previously activated T  ceils resulted in the expression of Fas-L mILNA 
and lysis  of Fas-positive target  cells.  Fas-L  antagonists  inhibited  AICD  of T  cell clones and 
staphylococcus enterotoxin B (SEB)-specific  T  cell lines.  The data indicate AICD in previously 
stimulated T  ceils is mediated by Fas/Fas-L interactions. 
M 
ature peripheral  T  cells generally undergo  activation 
. and proliferation when stimulated through the CD3/ 
TCR complex. Under certain circumstances,  however, thymo- 
cytes, T cell hybridomas, and both CD4 + and CD8 + T cell 
clones (TCC) 1 undergo cell death when stimulated through 
the TCR with CD3 antibody in the absence of APC (1-6). 
This process is rapid and exhibits classic characteristics of apop- 
tosis such as membrane blebbing, chromatin condensation, 
and the formation of DNA fragments of ",,200 bp. Deletion 
of T  cells by apoptosis appears to be important  not only in 
regulating  autoreactive  T  cells  in  the thymus,  but  also in 
regulating the peripheral T cell pool (7, 8). Little is known, 
however, about the mechanism that mediates the lytic process 
that has been termed activation-induced cell death (AICD). 
Fas/APO-1 (CD95) is a protein expressed on the surface 
of a variety of transformed cell lines and chronically stimu- 
lated T  cells  that can mediate apoptosis after ligation with 
a Fas-specific antibody (9-12). Under appropriate conditions 
Fas also transduces a stimulatory signal to certain B cell lines 
(13) and to .freshly isolated human peripheral blood T  cells 
and thymocytes (14).  To investigate a possible relationship 
between CD3-stimulated AICD and Fas-mediated T cell apop- 
tosis, we have used a mAb directed against human Fas (Fas 
M3). Immobilized Fas M3 mAb is able to lyse Fas-expressing 
tumor cell lines in a manner analogous to Fas-ligand (Fas-L) 
or the prototypic Fas mAb, CH-11, whereas soluble Fas M3 
blocks Fas-mediated killing  (15). 
1 Abbreviations used in this paper: AICD, activation-induced cell death; 
Fas-L, Fas-ligand; SEB, staphylococcal  enterotoxin B; TCC, T cell done, 
Materials and Methods 
T Cell Lines and Clones.  The alloreactive TCC used in this study 
were generated by establishing MLC in bulk culture for 7 d fol- 
lowed by limit dilution cloning in 96-well round-bottomed plates 
in the presence of 10  s irradiated allogeneic PBMC and 10 ng/mt 
of Ib2. TCC were maintained by stimulation with irradiated PBMC 
and soluble CD3 antibody (10 ng/ml) approximately every 2 wk 
and maintenance in IL-2 (10 ng/ml) between stimulations. Short- 
term staphylococcal enterotoxin B (SEB)-specific  T cell lines were 
established by stimulation  of PBMC  (106) with  5 /~g/ml SEB 
(Sigma Chemical Co., St. Louis, MO) for 3 d followed by expan- 
sion of cells in Ib2 (5 ng/ml). Cells were maintained in Ib2 for 
2 wk before use. 
Fas.Fc and Fas mAbs.  A Fas fusion protein  consisting  of the 
extracellular domain  of human  Fas coupled to the Fc region of 
human IgG1 (Fas.Fc) was generated as described (14). The anti- 
human Fas mAbs, M3 and M31, were derived from mice immunized 
with human Fas.Fc. When added in solution, Fas M3 blocks Fas- 
mediated lysis, whereas Fas M31 binds to Fas but has no agonistic 
or antagonistic properties  (15). 
Fas-L  Bioassay.  For  detection  of Fas-induced killing,  SlCr- 
labeled  Jurkat cells were incubated with varying numbers of effector 
cells for 18 h in the presence or absence of PMA (10 ng/ml) and 
ionomycin (500 ng/ml)  or immobilized  CD3 mAb (10/xg/ml), 
as described previously (15). Cultures  were performed in 96-well 
round-bottomed plates and harvested using  an  SCS harvesting 
system (Skatron, Sterling, VA). SlCr content  of supernatants was 
determined using an ME Plus gamma scintillation counter (Micro- 
medics, Huntsville,  TN). Percent specific StCr release was calcu- 
lated according to the formula 100 x  [(experimental cpm) -  (spon- 
taneous cpm)l/[(maximum cpm)  -  (spontaneous cpm)l, where 
spontaneous cpm  =  cpm released in the absence of effector cells 
and maximum cpm  =  cpm released in the presence of I N HC1. 
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DNA was isolated by PCR as described  (16). This PCR product 
was labeled  with  np by random priming and used  to probe a 
phage cDNA library prepared from activated human lymphocytes 
(17). Hybridization was at  37~  and the filters were washed  at 
55~  in 2 x  SSC. The purified phage cDNA inserts were amplified 
by PCR, digested  with EcoRI and subcloned into pBluescript  SK 
(Stratagene  Cloning Systems, La JoUa, CA). For expression of the 
human  Fas-L,  one of the  isolated  cDNAs (GenBank  accession 
number U08137)  was  excised by digestion with SalI/NotI and 
cloned into the mammalian expression vector pDC409 (18), which 
had been similarly digested.  The human Fas-L cDNA was trans- 
fected into 293 cells and supernatants  collected after 3 d and con- 
centrated tenfold before assay for biological activity. 
Flow Cytometric Detection of  Apoptotic Cells.  Detection ofapop- 
totic cells by muhiparameter flow cytometry used the fluorophores 
Hoechst 33342 and propidium iodide in combination with forward 
light scatter (19). Cells were analyzed using an Epics Elite cytom- 
eter (Coulter Corp., Hialeah, FL) equipped  with argon (488 nm 
emission) and helium-cadmium (325 nm emission) lasers. Immedi- 
ately before  analysis, Hoechst 33342  and propidium iodide  were 
added to single-cell suspensions  (10  ~ cells/ml)  such that final con- 
centrations  were 10 and 30/zM, respectively. Forward light scatter, 
log scale red fluorescence (propidium iodide, 675 nm) and log scale 
blue fluorescence  (HO342,  525 rim) were measured at a rate of 
700-800 cellsA, and the data stored in list mode. Cell debris and 
doublets were excluded by light scatter, and dead and necrotic cells 
by red fluorescence.  The data are plotted as blue fluorescence vs. 
forward light  scatter  contour histograms. 
Northern Blot Analysis.  Pbl cells were stimulated with immobi- 
lized CD3 mAb for varying time periods and total RNA was pre- 
pared  and Northern analysis performed, as described  (20), using 
a human Fas-L antisense riboprobe. Ribosomal RNA was stained 
with methylene blue to ensure  equal  loading in each lane. 
Assessment of  DNA Fragmentation.  For assessment of  DNA frag- 
mentation,  cell  pellets  were lysed in  10 mM Tris-HCl/10 mM 
EDTA/0.2% Triton X-100 and centrifuged (13,000 g) for 10 min 
(21). Supernatants  containing R.NA and fragmented DNA were 
extracted with phenol followed by phenol/chloroform/isoamyl al- 
cohol. The DNA/R.NA was precipitated  with ethanol, dried with 
a SpeedVac for 6 rain and dissolved in 15 #1 of 10 mM Tris/HC1/ 
1 mM EDTA. Samples were treated with 600 #g/ml of  RNase and 
electrophoresed  in 1% agarose gels and DNA was visualized under 
ultraviolet  light after  staining with ethidium bromide. 
Con  focal Microscopy.  Cells were stained  with a live/dead  via- 
bility/cytotoxicity kit as recommended by the manufacturer (Mo- 
lecular  Probes  Inc., Eugene, OR.).  Live cells were distinguished 
by their  ability to convert nonfluorescent calcein  AM to green 
fluorescent  calcein  via  intracellular  esterase  activity.  Ethidium 
homodimer stains the DNA of  cells with damaged membranes and 
fluoresces red. Cultures were examined with a confocal laser scan- 
ning microscope (Molecular  Dynamics, Sunnyvale,  CA). 
Results 
Fas-L Induces ApoFtosis in Human  T Cell Clones.  Initially, 
we compared the ability of immobilized Fas  M3 mAb and 
recombinant  human Fas-L (rFas-L)  to induce  apoptosis  in 
chronically stimulated aUoreactive CD4 + and CD8 + human 
TCC.  Cell  viability  was  assessed  using  a  muhiparameter 
flow cytometric technique that discriminates apoptotic from 
necrotic cell death based upon measurement of forward light 
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Figure  1.  Immobilized Fas M3 mAb and rFas-L induce apoptosis in 
CD4 + TCC which is blocked by soluble Fas M3 mAb. PL-1 cells were 
cultured for 18 h in medium alone, rFas-L (1:5 dilution of 10x  superna- 
tant), or in wells that contained immobilized Fas M3 mAb either in the 
presence or absence of soluble Fas M3 mAb (10 #g/ml).  Fas M3 mAb 
was immobilized in 24-well culture plates for 4 h at room temperature 
at 10 #g/ml in PBS followed  by six washes with PBS. Cells were recovered 
and analyzed for apoptosis by muhiparameter flow cytometry. The per- 
cent apoptotic cells is indicated. Data are representative of ten experiments. 
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Figure  2.  PL-1 cells stimulated with either PMA plus ionomycin or 
immobilized CD3 mAb are active in a bioassay for Fas-L activity. 51Cr- 
labeled Jurkat target cells were cultured for 24 h with PL-1 cells cultured 
in (.4) medium, (B) PMA (10 ng/ml) plus ionomycin (500 ng/ml), or 
(C) immobilized CD3 mAb (10 #g/ml) in the absence (open circles) or 
in the presence of soluble Fas M3 (open squares) or Fas M31 (solid circles) 
mAb (10 #g/ml). (D) Jurkat target cells were cultured with titrated con- 
centrations of control supernatant (open circles), or rFas-L supernatant ei- 
ther alone (solid circles) or with Fas M3 mAb (open squares) or Fas M31 
mAb (solid squares). Neither PMA plus ionomycin  nor CD3 mAb affected 
the spontaneous release of SlCr by Jurkat cells cultured in the absence of 
PL-1 effector cells. Data are representative of five experiments. 
72  Human Fas-Ligand Figure  3.  Regulation  of Fas-L 
transcription in CD3 mAb stimu- 
hted PL-1  cells. PL-1  cells  were  cul- 
tured for varying time periods, 
RNA was prepared and Northern 
analysis of total RNA performed 
using a human Fas-L antisense 
riboprobe. Ribosomal  R.NA  was 
stained with methylene  blue  to en- 
sure equal loading in each lane. 
scatter and the DNA binding fluorophores propidium iodide 
and  Hoechst  33342.  The  alloreactive  CD4 +  TCC,  PL-1, 
showed little evidence of apoptotic cell death when cultured 
for 18 h in medium alone (Fig. 1). Upon culture with either 
rFas-L or immobilized Fas M3 mAb, however, almost 60% 
of cells were determined  to be undergoing  apoptosis (Fig. 
1).  In addition,  soluble Fas M3 mAb, which had no effect 
on PL.1 viability when added alone, efficiently blocked apop- 
tosis induced by either rFas-L or immobilized Fas M3 mAb. 
Similar results were obtained when cell viability was assessed 
in a panel of TCC (six CD4 + and two CD8 + TCC gener- 
ated from three individual donors) and by a variety of other 
techniques,  including  trypan blue dye exclusion,  3-(4,5-di- 
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
conversion, propidium iodide uptake,  and by a DNA frag- 
mentation  assay  (data not  shown). 
Human T Cell Clones Express Fas-L.  We have recently de- 
veloped a sensitive bioassay to detect the presence of Fas-L 
which uses the Fas-sensitive human  T  cell line Jurkat  as a 
target cell in a SlCr-release cytotoxicity assay (15). This assay 
was demonstrated to be specific for Fas-L because Jurkat cells 
are not lysed by either TNF or lymphotoxin-oe and because 
soluble Fas M3 mAb blocked cytolysis by effector cells in- 
duced to express Fas-L.  PL-1 cells cultured in the presence 
of either PMA plus ionomycin or immobilized CD3 mAb 
induced lysis of  Jurkat cells, whereas nonactivated TCC had 
little effect (Fig.  2). The lysis of Jurkat target cells induced 
by either of these stimuli was almost completely inhibited 
by the addition of soluble Fas M3 mAb, but not by the non- 
neutralizing  Fas M31 control mAb. In addition,  rFas-L was 
strongly lytic toward Jurkat target cells, and its activity was 
blocked completely by soluble Fas M3 but not by Fas M31 
mAb  (Fig.  2  D). 
The kinetics of Fas-L expression by PL-1 cells after activa- 
tion were determined by Northern analysis. Little or no Fas- 
L-specific mRNA was detected in nonstimulated  PL-1 cells 
(Fig.  3).  Within  30 min  of stimulation  with  immobilized 
CD3 mAb,  however, PL-1 cells expressed significant  Fas-L 
mRNA  which peaked at  ~1  h  after stimulation. 
Fas Antagonists Block AICD  Our data indicate that TCC 
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Figure 4.  Fas antagonists in- 
hibit AICD in TCC. Apoptosis 
was measured in  PI~I cells by 
Hoechst 33342 staining after 18 h 
stimulation. Fas.Fc and  TNFK 
(p75).Fe are fusion proteins con- 
sisting of the extraceUular  domain 
of either Fas or the p75 TNF re- 
ceptor coupled to human IgG1 
and were used at 10/~g/ml. The 
Fas antibodies  (M3 and M31)  were 
used at 10 #g/ml. Data are repre- 
sentative of ten experiments. [] 
O;  ￿9  Fas M31; [] Fas M3; [] 
TNFK.Fc; [] Fas.Fc. 
are both susceptible to Fas-mediated apoptosis and can be in- 
duced to express Fas-L (Figs.  1-3). Therefore, the interaction 
of this cognate pair may account for the AICD  seen upon 
exposure of TCC to stimuli such as CD3 mAb or phorbol 
ester plus calcium ionophore.  To directly test this hypoth- 
esis, we used antagonists of Fas in an attempt to block apop- 
toffs induced by CD3 mAb or PMA plus ionomycin. Soluble 
Fas M3 mAb blocked AICD in PL-1 cells induced by either 
of these stimuli,  whereas  the control mAb,  Fas  M31,  had 
no effect (Fig. 4). Neither Fas mAb affected cell viability in 
the absence of stimulation.  AICD induced by phytohemag- 
glutanin was also strongly inhibited by soluble Fas M3 anti- 
body, and similar results were obtained with four other TCC 
(data not  shown). 
To determine whether blocking of AICD in TCC was due 
to interference with  the interaction  of Fas with its ligand, 
or whether the Fas M3 mAb acted by signaling  the T  cells 
directly, we tested the effect of a soluble Fas.Fc fusion protein 
on AICD. Fas.Fc blocked AICD, whereas the TNFR(p75).Fc 
had no effect (Fig.  4). Thus, AICD in T  cells is dependent 
upon Fas-L but appears to be independent of TNF. To confirm 
that the AICD observed using the Hoechst staining method 
was apoptotic cell death, we isolated DNA from cells stimu- 
lated as in Fig. 4 and confirmed that AICD was associated 
with oligonudeosomal DNA degradation (Fig. 5). CD3 mAb- 
induced DNA fragmentation was specifically blocked by the 
Fas  antagonists  Fas  M3  and Fas.Fc  but not by the control 
antibody or fusion protein  (Fig.  5). 
Fas Antagonists Block Superantigen AICD  Superantigens 
stimulate a large percentage of T cells via their ability to simul- 
taneously bind to class II MHC and V3 TCR (22, 23).  In 
animal models, superantigens, which include many bacterial 
toxins such as SEB, cause an initial expansion of T  cells ex- 
pressing  the appropriate V3 gene followed by deletion of these 
cells to amounts lower than in unchallenged animals  (24-27). 
Deletion of superantigen-specific human T cell lines has also 
been observed in vitro  and occurs by an apoptotic process 
(28, 29). To assess whether superantigen-induced  T  cell de- 
letion also involves Fas/Fas-L interactions,  we established short- 
term SEB-specific T cell lines and tested whether SEB-induced 
AICD could be blocked by Fas antagonists.  We found both 
soluble Fas M3 mAb and Fas.Fc completely inhibited AICD 
induced by SEB (Fig.  6). These Fas antagonists also blocked 
73  Alderson  et al. Fas M3 mAb (Fig. 7 C). PL-1 cells cultured with CD3 mAb 
formed tight clusters of cells and within the clusters were 
apposing live and dead cells (Fig. 7 D). With the addition 
of soluble Fas M3 mAb, cell clusters were not disrupted and 
few, if any, dead cells were detected within the clusters (Fig. 
7 E). These results suggest that the lytic processes of AICD 
induced by CD3 stimulation  require direct cell-cell contact 
and are completely inhibitable by addition of antagonists of 
Fas/Fas-L interactions. 
Figure 5.  Fas antagonists block DNA fragmentation in TCC induced 
by CD3 ligation.  Cells were analyzed for DNA fragmentation  after 8 h 
stimulation.  Data  are representative of four experiments. 
AICD stimulated by CD3 mAb in the SEB-specific T  cell 
lines (data not shown). 
Visualization of  AICD  by Confocal Microscopy.  To directly 
visualize the effect of soluble Fas M3 mAb on AICD, the 
process was examined by confocal microscopy using fluoro- 
phores that discriminate live (green  fluorescence) from dead (red 
fluorescence) cells. PL-1 cells cultured overnight  in medium 
alone were ~>98% viable (Fig. 7 A), whereas widespread cell 
death was evident in cells cultured with rFas-L (Fig. 7 B). 
This lytic effect  was completely  inhibited by addition of soluble 
5o7  Figure 6.  Fas  antagonists 
_~  |  [-~  block  AICD  in SEB-specific  T-cell 
401  ]L  lines. Short-term  SEB-specific  T 
.o  30  cells were  stimulated  with  SEB (5 
/~g/ml)  for 18 h and apoptosis  was  ~-  20  g  ~  measured by  Hoechst  staining. 
.c  10  ]  ~  Data are representative of four ex- 
~  ~  periments.  [] 0; g  Fas M31; [] 
Medium  SEB  Fas M3;  []  Fas.Fc. 
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Discussion 
Apoptosis is believed to play an important role in the dele- 
tion of  autoreactive  or unwanted T cells  in two different phases 
during the ontogeny of the immune response. First, the en- 
counter of self-antigens in the thymus leads to T cell dele- 
tion characterized  by apoptotic cell death. Thymic T cell apop- 
tosis, however, appears to be independent of Fas, because mice 
homozygous for the llor mutation, which results in expres- 
sion of a defective Fas molecule (30, 31), appear to delete 
autoreactive T cells in a normal manner (32). Second, chron- 
ically stimalated mature T cells can be eliminated in the pe- 
riphery by the process of AICD (1-6).  The data presented 
in this paper suggest that Fas-L is critically involved in AICD 
of mature T  cells, and it therefore seems likely that Fas-L 
is the prime mediator of the peripheral deletion of T  cells 
and maintenance of peripheral self-tolerance. Thus, it may 
be possible that antagonists of  Fas will block peripheral dele- 
tion and tolerance induction in vivo, and perhaps lead to the 
development of autoimmune reactivity. 
In addition to eliminating self-reactive T cells in the pe- 
riphery, Fas-L may serve to limit the expansion of antigen- 
activated lymphocytes by mediating AICD in a proportion 
of  cells that reencounter their antigen or in cells that remain 
activated after elimination  of their cognate antigen.  In this 
sense, Fas-L would prevent excess accumulation  of antigen- 
reactive T cells. This is consistent with the pathophysiology 
observed in Ipr/Ipr mice which display a progressive develop- 
ment of an autoimmune disease process characterized in part 
by the accumulation  of T cells with an unusual phenotype 
(33). Thus, a defect in Fas would result in the failure of T 
cells to undergo AICD and result in their gradual accumula- 
tion, including those cells specific for self-antigens. 
A recent analysis of cell surface molecules involved in su- 
perantigen AICD suggested that LFA-1/intercellular adhe- 
sion molecule 1 (ICAM-1) interactions are involved because 
an antibody to LFA-1 partially blocked cell death (34). Our 
data  do  not  preclude  an  accessory involvement  of LFA- 
1/ICAM-1  in the adhesion of cells undergoing AICD, but 
Fas-L most likely provides the signal that actually initiates 
the apoptotic  process. 
The involvement of Fas in AICD was recently suggested 
by experiments that demonstrated that T cells derived from 
Ilyr/Ipr  mice are defective  in AICD (35, 36). In addition, gld/gld 
mice show a similar defect in AICD and thus it was sug- 
gested that the  g/d product links the CD3/TCR and Fas apop- 
totic pathways (37). These observations, together with the 
recent demonstration that gld/gld mice have a mutation in F
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 the Fas-L gene (16, 38), support a role for Fas and Fas-L in 
AICD. Their precise mechanism of action in AICD in normal 
T cells, however, was not addressed. Data presented here not 
only directly demonstrate  that  AICD  in normal  activated 
human T  cells involves Fas-L/Fas but further  demonstrate 
the process by which this interaction occurs. Thus, we show 
the induction of expression of Fas-L by activated T cells upon 
activation,  susceptibility to recombinant F~_s-L-mediated  killing 
by these same T cells, and finally that although antagonists 
of Fas do not block dustering  of T  cells induced by TCR 
ligation,  they virtually completely inhibit  the induction of 
apoptosis. In contrast,  an antagonist  of TNF had no effect 
on AICD suggesting that this process is independent of the 
TNF/TNFP,  apoptotic pathway. 
Fas-L  expression by activated CD4 + and CD8 + T  cells 
may shed light on the mechanism of TNF-independent  cy- 
tolysis mediated by CD4 + cytolytic T  cells and non-MHC- 
restricted  cytolysis mediated by CD8 + T  cells.  T  cells in- 
duced  to  express  Fas-L  lyse target  ceUs susceptible to  Fas 
antibody-mediated cytolysis (Fig.  2), which includes a wide 
variety of transformed  cell lines  (9-12L  The role of Fas-L 
in T cell-mediated cytolysis is supported by two recent studies 
suggesting that Fas is a major target for CD4 + T  cell-medi- 
ated cytolysis (39)  and  that  a component  of CD8 +  CTL 
killing involves Fas-L  (40). 
AICD mediated through Fas may have broader implica- 
tions for the immune response and autoimmune disease in 
general.  For example, AICD has been observed in T  cells 
freshly isolated from HIV-infected, but not from uninfected, 
individuals (41, 42). Thus, apoptosis may play a role in the 
diminution of CD4 + T  cells and the progression to AIDS 
in  HIV infected individuals.  The AICD  seen  in  activated 
normal  T  cells and in freshly isolated T  cells  from HIV + 
individuals  is qualitatively identical,  and it is tempting to spec- 
ulate that Fas/Fas-L may be involved in this process in AIDS 
patients. If so, therapeutic intervention for HIV-infected in- 
dividuals with a Fas antagonist may be possible. The recent 
molecular cloning of a rat  and mouse ligands  for Fas (16, 
38, 43) and the human Fas-L described herein will facilitate 
the determination of the precise role for Fas ligand in AICD 
in both normal immune responses and in responses where 
apoptosis appears to be disreguhted, such as in HIV infection. 
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